Skip to main content
    H

    Hims Hers Health Inc (HIMS)

    Official site

    HEALTHCARE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $18.55
    -1.18 (-5.98%)

    Market Cap: $4.62B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Hims Hers Health Inc (HIMS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Hims Hers Health (HIMS) to earn -$0.83 per share in the fiscal year ending Dec 31, 2026, on revenue of $3.14B. Of 15 analysts, 3 rate the stock Buy or Strong Buy, 12 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 15 ratings average 2.67, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 20% of the ratings.

    RatingAnalystsShare
    Strong Buy213.3%
    Buy16.7%
    Hold1280.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    15

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 22.9%.

    Fiscal year ending Dec 31, 2026
    -$0.83
    EPS consensus, revenue $3.14B
    Fiscal year ending Dec 31, 2027
    $0.07
    EPS consensus, revenue $3.86B
    Next report
    Feb 22, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.83-$1.15 to -$0.4611$3.14B$3.13B to $3.18B13
    Dec 31, 2027$0.07-$0.37 to $0.4511$3.86B$3.68B to $4.37B14

    Quarterly Estimates

    The EPS consensus falls from $0.12 for the quarter ending Dec 31, 2026 to -$0.06 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.12-$0.02 to $0.3315$924.38M$863.38M to $1.10B14
    Mar 31, 2027-$0.06-$0.20 to $0.014$904.06M$860.90M to $953.50M5

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 1 upward and 3 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202602
    Fiscal year ending Dec 31, 202711
    Quarter ending Mar 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.46.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.83-$0.56-$0.56-$0.56-$0.46N/A
    Fiscal year ending Dec 31, 2027$0.07$0.42$0.42$0.42$0.59-88.3%
    Quarter ending Mar 31, 2027-$0.06$0.05$0.05$0.05$0.07N/A

    Frequently Asked Questions About HIMS

    What is the HIMS stock forecast?

    Consensus analyst estimates put Hims Hers Health's EPS at -$0.83 for the fiscal year ending Dec 31, 2026, on revenue of $3.14B. The consensus rating from 15 analysts is Hold.

    How do analysts rate HIMS stock?

    Of 15 analysts covering Hims Hers Health, 2 rate it Strong Buy, 1 Buy, 12 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from HIMS next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.83, with estimates from -$1.15 to -$0.46 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.07, with estimates from -$0.37 to $0.45 from 11 analysts.

    What revenue do analysts expect from Hims Hers Health next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $3.14B, with estimates from $3.13B to $3.18B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.86B, with estimates from $3.68B to $4.37B.

    How many analysts cover HIMS?

    15 analysts rate Hims Hers Health stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.